The firm's CEO expects lab capital expenditures to return to normal by the second half of 2026 as the overall life science ...

The company said that preliminary Q4 revenue was up 39 percent year over year and full-year 2025 revenue increased 35 percent ...

The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' ...

Altai Capital said last month it had "serious concerns about the company’s significant share price underperformance." ...

NEW YORK – Siemens Healthineers has been granted funding from the Gates Foundation to support development of a maternal health screening tool, the firm announced on Friday. The total amount of the ...

In a presentation, executives discussed upcoming data readouts and their potential effect on reimbursement for the firm's FirstLook Lung test.

Chairman and CEO Adam Schechter said that deals may open up as hospital systems grow concerned about Medicaid cuts and the end of Affordable Care Act subsidies.

Diagnostics is already operating somewhat separately from the firm's other two business units under its new organizational structure, company officials said.

NEW YORK — Several Delta Dental dental health plan administrators said on Thursday that they will begin coverage of OraLiva's oral cancer test.

President and CEO Jim Davis said he believes PAMA reform will pass this year but said another temporary delay will likely be needed to postpone cuts slated for February 1.

NEW YORK — Point-of-care testing firm Truvian Health said on Monday that nine tests that run on its TruVerus benchtop blood analyzer have received 510(k) clearances from the US Food and Drug ...

The CitoCBC system received FDA 510(k) clearance and CLIA waiver almost a year ago and provides results in about eight minutes in near-patient settings.